In recent years, some studies have investigated the idea of exploiting the circadian clock in tumors for therapy, for instance, by modulating activity of circadian clock molecules [14], enhancing intra-tumor circadian rhythms [15], and optimizing anticancer drug delivery by timing it to the host’s circadian rhythms [16,17]. This evidence concerns the gene CLOCK and neoplasm.